John Neis

John P.
Neis currently works at National Venture Capital Association, as Director, Wisconsin Venture Capital Association, as President & Director, Virent, Inc., as Director, Venture Investors LLC, as Managing Director from 2001, Cellectar Biosciences, Inc., as Independent Director from 2008, TAI Diagnostics, Inc., as Director, UpSkill LLC, as Director, Delphinus Medical Technologies, Inc., as Director from 2015, The Morgridge Institute for Research, Inc., as Trustee, and the University of Wisconsin Business School, as Advisory Board.
Mr. Neis also formerly worked at Prevacept Infection Control, Inc., as Director, Mithridion, Inc., as Director, Wisconsin Technology Council, as Director, Novelos Therapeutics, Inc., as Independent Director from 2011 to 2014, NimbleGen Systems, Inc., as Director, Inviragen, Inc., as Director, TomoTherapy, Inc., as Director from 1999 to 2008, Cellectar, Inc., as Director from 2008 to 2011, Third Wave Technologies, Inc., as Director, Wisconsin Growth Capital Coalition, as Director, and Deltanoid Pharmaceuticals, Inc., as Director.
Mr. Neis received his undergraduate degree in 1978 from the University of Utah and graduate degree in 1986 from the University of Wisconsin.